Member Info for LOTM-13

Might want to watch APTA ..... they were up posting this at 07:46 this morning.....

https://www.linkedin.com/posts/the-aptamer-group_apta-investorrelations-irchat-activity-7359112325758439426-sXqU

📢 Don’t miss our investor webinar tonight at 6:00 pm (BST).

Our CEO, Arron Tolley, and CFO, Andrew Rapson, will be discussing the latest company developments highlighted in the recent trading update.

🔗 Register to join and get your questions answered here: https://lnkd.in/eBeNVEgG

Got a feeling there holding this after hours for a reason ............

LOTM

Company is on the go early this morning on Linkedin this from 07:46 https://www.linkedin.com/posts/the-aptamer-group_apta-investorrelations-irchat-activity-7359112325758439426-sXqU

📢 Don’t miss our investor webinar tonight at 6:00 pm (BST).

Our CEO, Arron Tolley, and CFO, Andrew Rapson, will be discussing the latest company developments highlighted in the recent trading update.

🔗 Register to join and get your questions answered here: https://lnkd.in/eBeNVEgG

I have the feeling they are really trying to get APTA shareholder & investor attention tonight for a reason!

LOTM

Aldebaran,

When you register for the webinar, it asks you if you have any questions you want to submit :)

LOTM

Looking forward to tonight's webinar.

Hoping for some really good news & pointers ..........

GLA

LOTM

Are we seeing another in-day sentiment reversal ?

I guess we'll find out in due course!

LOTM

Back to Shrinkage posts!

https://www.linkedin.com/posts/thruvision_lossprevention-retaildistribution-shrinkage-activity-7358783995557412866-OdGq

When high-value luxury items vanish from your inventory, it's more than just a loss. Employee theft is a silent drain on profits in retail distribution, especially when it comes to coveted goods.

Thruvision's advanced security screening solutions are specifically designed to help you uncover and prevent internal theft. We provide the discreet yet powerful capabilities you need to ensure your luxury products remain secure, from warehouse to display. Don't let your inventory disappear without a trace, contact our team. https://bit.ly/4ok5J3b

So I guess we're not going to be seeing any new signed orders anytime soon :( so much for the orders they were expecting to close in July.

Back to a waiting game I guess

LOTM

I guess we should be looking for a large sell order trade to come through at some point, hence the MM's keenness to keep lowering the offer price until it was covered.

Now its covered will the share price bounce or have we ran out of new buyers for now.

LOTM

Morning Imperiallondon,

I'll have to put those stocks on one of my watch lists then!

Its noticeable how many new followers APTA has gained on Linkedin over the past couple of weeks!

The company seems to be using Linkedin much more now to communicate with than it did previously as well.

LOTM

I decided to join in on the top-ups, trade 31 is mine another 0.5M at 0.4822p giving me 2.5M now.

Just can't shake the feeling that this Webinar is after the market closes tomorrow for a reason!

GLA

LOTM

Welcome onboard Quimada,

Most buys are showing as sells just like they were for most of yesterday!

LOTM

Hi ant15,

That's the point I was making very early this morning, especially when you tie it in with the Linkedin comment from APTA on Monday about the Sunday Mail Midas article being a "very good start to the week".

LOTM

Hi affrm,

Well I don't think Unilever & AstraZeneca are interested in products that would only generate small amounts of profits for them. They need big numbers to make a material difference to their bottom lines.

APTA are negotiating Royalty payments for successful products & thus get a small share of the sales/profits generated rather than miss out on something big by taking an upfront reward instead. With a current market cap of just £14M & £3M in the bank currently & the start of consistent revenue from royalties possibly starting as early as the end of the year on a different product from the Unilever & AstraZeneca ones, I think the future is very bright indeed.

Personally I want to continue to keep building my position here & will at times risk trading my APTA stock to do so. I'll also be trading other stocks with a view to putting some of those profits into APTA as well over the coming months. I have 2M shares but want to see that grow to 3M, then 4M, then 5M etc.

The worry for me is someone coming along with a cheeky offer to buy it on the cheap before the true value of all its potential revenue streams becomes apparent to the majority of investors.

Good luck with what you decide to do.

LOTM

The timing of the Webinar is very interesting in itself !

Is it at that time of the day (after UK markets are closed) simply to allow great USA participation with it, or are they going to announce something just before it!

As it feels like a co-ordinated approach given the Sunday Mail Midas article !

LOTM

A really interesting interview yesterday (7 mins long) with this linkedin post that we all seem to have missed spotting!

https://www.linkedin.com/posts/the-aptamer-group_aptamers-antibodyalternatives-crueltyfreescience-activity-7358429519461994496-B7IR

We are supporting many companies to move away from animal-derived affinity ligands. 🧬✨

Check out this short video 🎥 from the Danish Society for the Protection of Laboratory Animals, to learn how Optimer is entirely animal-free, from discovery to manufacture. 🐾❌

Allowing scientists to hit new targets 🎯 and tune performance ⚙️, Optimer offers a more ethical approach to research, diagnostics, and therapeutics. 🌍💉🔬

Alderbaran, again answering some of your questions.

LOTM

Alderbaran,

I think these are what you were looking for regarding TAM & timescales etc including Unilever, AstraZeneca who will have been all over Patents (54+) etc before hand especially when you're talking significant royalties on the back of the finished products.

https://aptamergroup.com/wp-content/uploads/2025/04/Aptamer-Group-Corporate-Factsheet-Apr-2025_01.pdf

https://aptamergroup.com/wp-content/uploads/2025/04/Aptamer-Group-Corporate-Presentation-Apr-2025.pdf

LOTM

Aldebaran,

I think this is what your looking for https://aptamergroup.com/knowledge-centre/

Then I refined it a bit for patents for you https://aptamergroup.com/aptamer-intellectual-property/

LOTM

Optimiser seems to have so many potential uses already Aldebaran, which makes it really difficult to know what it can or can't do. Just look at the range of potential products, deodorants, to test kits, to fibrotic liver, to animal genetic health.

https://aptamergroup.com/portfolio/

From Cancer UK tab - Aptamer Group is working with Cancer Research UK and Dan Wiseman and the Oglesby Leukaemia Research Programme at the University of Manchester. The project will explore the potential of bifunctional Optimer® therapeutics for the treatment of Chronic Myelomonocytic Leukaemia (CMML) and other myeloid malignancies.

LOTM

Hi Aldebaran,

Sorry I'm not technical enough to answer that question, have you looked on the Aptamer website? because they are using Optimiser with other companies to target certain cancers etc.

If it's not there then you could submit as a question ahead of the Webinar on Thursday 5pm

LOTM

Into the 0.5x's we go

LOTM

Hi joseywales & Walkietalkie,

I hope you are both well ?

hmm SYNT continues to underwhelm, there is only so much that "self-help" & "non core disposals" will do for a business, at some point in time you have to increase your earnings especially when you have a bigger & bigger debt mountain to fund. There going to need another rights issue or such like as big if not bigger than the last one (in £'s) at this rate.

LOTM